Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd.

Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd. was established in 1999 in Zhangjiang Hi-Tech Park, Shanghai, covering an area of 50,000 square meters, with a total investment of USD 59 million. It is a wholly-owned subsidiary of Daiichi Sankyo Co., Ltd., a global innovator in original drug development. The company is primarily engaged in the development, production, sales, and consulting of pharmaceuticals, as well as the import and export and wholesale of pharmaceuticals.
As the core of Daiichi Sankyo's operations in China, the company strives unremittingly to realize the corporate vision of (Global Drug Innovator) for the entire group, continuously introducing excellent products and technologies from the parent company, strictly following GMP requirements for production and quality control, and delivering the latest clinical drug information and treatment methods to medical professionals in a timely and accurate manner with professional service awareness and dedication, contributing to improving the quality of life for patients.
We solemnly promise: Tomorrow's China will be healthier!